This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Matteo Magnani: Innovator in Pharmaceutical Advancements
Introduction
Matteo Magnani is a notable inventor based in Pratovecchio, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Alzheimer's disease. With a total of 2 patents, his work is recognized for its potential impact on medical science.
Latest Patents
Matteo's latest patents focus on S1P3 antagonists. The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, specifically for the treatment of Alzheimer's disease. This innovative approach highlights his commitment to addressing critical health challenges.
Career Highlights
Matteo Magnani is associated with Teva Pharmaceutical Industries Limited, where he applies his expertise in pharmaceutical research and development. His work is instrumental in advancing therapeutic options for patients suffering from neurodegenerative diseases.
Collaborations
Some of his coworkers include Chiara Caramelli and Cesare Federico, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Matteo Magnani's contributions to pharmaceutical innovations, particularly in the treatment of Alzheimer's disease, underscore his role as a leading inventor in the field. His ongoing work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile